Skip to main content
. 2020 Mar 3;11:180. doi: 10.3389/fphar.2020.00180

Figure 2.

Figure 2

Effects of exposing three colorectal cancer cell lines to increasing concentrations of decitabine (DAC) on their proliferation, as determined by MTT assay. (A) Proliferation of human SW480 cells in percent of untreated control after exposure to increasing concentrations (0.25, 0.5, 1, 2, 4, 8, 16 µM) of decitabine (DAC) for 24 to 96 h. (B) Proliferation of human SW707 cells in percent of untreated control after exposure to increasing concentrations (0.5, 1, 2, 4, 8, 16, 32 µM) of decitabine (DAC) for 24 to 96 h. (C) Proliferation of rat CC531 cells in percent of untreated control after exposure to increasing concentrations (0.5, 1, 2, 4, 8, 16, 32 µM) of decitabine (DAC) for 24 to 96 h.